Trust Board papers November 2012 - Barking Havering and ...

PRINCIPAL RISK
What could prevent the objective being
achieved
Risk no, Date on Risk Register
& Risk Scoring:
KEY EXISTING CONTROLS
What controls/systems are in
place to assist in securing delivery
of objective and managing
principle risks?
CQC REF:
RESIDUAL RISK
ASSURANCES ON
CONTROLS & IMPACT
Where we gain evidence
that our controls/systems, on
which we are placing
reliance, are effective? The
impact following assurances.
PROGRESS AGAINST
RISKS/ ACTION
PLAN UPDATE
What Actions are undertaken to
mitigate the actual risks?
GAPS IN ASSURANCE
Where we are failing to gain
evidence that our controls /
systems, on which we place
reliance, are effective
GAPS IN
CONTROL
Where are we
failing to put
controls / systems
in place? Where are
we failing in making
them effective?
LEAD
Strategic Objective 5 – To Ensure BHRUT is Financially Secure
Principal Objective: The CIP be delivered fully to the agreed timescales without affecting the quality of care adversely
Risk No: 292 Clinical
Directorates will not
achieve financial target
and CIP deliveries
Previous descriptor: Trust
would not achieve financial
balance
Date on Register: 15.06.2011
Rating Scoring:
Severity:5 x Likelihood:5 = 25
Area: All Clinical
Impact on:
Patient: Poor patient outcome
Staff: none
Trust: The Trust sustaining
progressive measures
Details updated 24.10.12
**All financial risks will be
reviewed by the newly
appointed Finance Director
8.10.12
- Trust has prepared Clinical
Strategy and Long-Term
Financial Model (with support
from EY) - reviewed at
October Trust Board. Model
shows Trust reducing but not
eliminating deficit by 2017/18,
although further options are
now being reviewed.
- PMO with support from EY is
developing CIP plans for
2013/14 and ensuring full year
benefit from existing schemes
meets 2012/13 target
4 16
Extreme Red
8.10.12
- Review of Clinical
Strategy, LTFM,
CIP/Transformation
programme by
Transformation Board,
Finance Committee,
Trust Board, NHS
London and
Commissioners.
Executive sponsorship of
all programmes.
8.10.12
Ongoing work to finalise
clinical strategy and LTFM
and CIP plan for 2013 /14
8.10.12
- Further options to be
fully developed to
demonstrate financial
viability in the longer
term
- Full year CIP
programme yet to be fully
developed
None identified
following review
David Gilburt Finance Director / Alan Davies Deputy Director of Finance
BHRUT BAF 2nd Quarter 2012: SB/PS
14